Si-Bone (SIBN) Capital Expenditures (QoQ) (2018 - 2026)
Si-Bone (SIBN) Capital Expenditures (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Si-Bone | 753.03 Mn | 608.35 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 107.92% |
| Dec 31, 2025 | -208.54% |
| Sep 30, 2025 | 679.05% |
| Jun 30, 2025 | -150.92% |
| Mar 31, 2025 | -77.11% |
| Dec 31, 2024 | 341.39% |
| Sep 30, 2024 | -194.53% |
| Jun 30, 2024 | 223.05% |
| Mar 31, 2024 | 12.35% |
| Dec 31, 2023 | -82.36% |
| Sep 30, 2023 | 399.47% |
| Jun 30, 2023 | -180.22% |
| Mar 31, 2023 | 138.31% |
| Dec 31, 2022 | -288.47% |
| Sep 30, 2022 | 78.51% |
| Jun 30, 2022 | -12.01% |
| Mar 31, 2022 | -61.56% |
| Dec 31, 2021 | 259.13% |
| Sep 30, 2021 | -267.81% |
| Jun 30, 2021 | 12.10% |